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We describe, for the first time, the generation of a viral DNA chip for simultaneous expression measurements
of nearly all known open reading frames (ORFs) in the largest member of the herpesvirus family, human
cytomegalovirus (HCMV). In this study, an HCMV chip was fabricated and used to characterize the temporal
class of viral gene expression. The viral chip is composed of microarrays of viral DNA prepared by robotic
deposition of oligonucleotides on glass for ORFs in the HCMV genome. Viral gene expression was monitored
by hybridization to the oligonucleotide microarrays with fluorescently labelled cDNAs prepared from mock-
infected or infected human foreskin fibroblast cells. By using cycloheximide and ganciclovir to block de novo
viral protein synthesis and viral DNA replication, respectively, the kinetic classes of array elements were
classified. The expression profiles of known ORFs and many previously uncharacterized ORFs provided a
temporal map of immediate-early (a), early (b), early-late (g1), and late (g2) genes in the entire genome of
HCMV. Sequence compositional analysis of the 5* noncoding DNA sequences of the temporal classes, per-
formed by using algorithms that automatically search for defined and recurring motifs in unaligned sequences,
indicated the presence of potential regulatory motifs for b, g1, and g2 genes. In summary, these fabricated
microarrays of viral DNA allow rapid and parallel analysis of gene expression at the whole viral genome level.
The viral chip approach coupled with global biochemical and genetic strategies should greatly speed the
functional analysis of established as well as newly discovered large viral genomes.
Human cytomegalovirus (HCMV) has one of the largest
known viral genomes, with a complexity that approximates 0.25
Mb of double-stranded DNA. The complete genome sequence
of the AD169 laboratory strain of HCMV was made available
in 1990 (4). Analysis of this sequence and of related laboratory
and clinical strains for potential protein-coding content has
revealed at least 226 distinct open reading frames (ORFs) (3,
4, 23). To date, expression analysis of the HCMV genome has
resulted in the characterization of approximately 30% of the
genome (reviewed in reference 22 and Table 1).
The expression of HCMV genes upon infection is tempo-
rally regulated. The first genes expressed (immediate-early [IE
or a] genes) are independent of any viral de novo protein
synthesis and encode mostly regulatory trans-acting factors.
The next set of genes expressed (early [E or b] genes) requires
the presence of the viral IE proteins and contributes an essen-
tial source of factors, including viral DNA replication, repair
enzymes, and other nonstructural proteins, such as those that
serve in immune evasion. Late (L or g) genes are essentially
expressed after the onset of viral DNA replication and con-
tribute primarily to assembly and morphogenesis of the virion.
Thus, the time of viral gene expression during infection is an
important clue to its functional role. Systematic approaches
that permit high throughput evaluation of specific ORF ex-
pression would greatly assist efforts to elucidate viral gene
function of highly complex viruses, such as CMV, on a ge-
nome-wide scale. Historically, prominent regions of HCMV
IE, E, and L gene expression were initially identified by hy-
bridization to genomic subfragments, and therefore these early
studies provided a first analysis of the HCMV transcription
program (5, 19, 31, 34, 36).
Recently, DNA chips have been constructed and used to
measure genome-wide expression levels of genes in plants,
bacteria, yeast, and human cells (6, 25, 27, 28 and references
therein). Of these methods, DNA microarrays, consisting of
individual ORF sequences printed in a miniaturized format on
glass, is a relatively simple but powerful tool for studying gene
expression on a large scale (28). Here, we report on the con-
struction of a viral DNA chip for HCMV. These fabricated
microarrays of viral DNA allow, in a single hybridization, the
analysis of gene expression for many of the predicted HCMV
ORFs. In the present study we have applied this technique to
examine the temporal transcription program of HCMV gene
expression. HCMV array elements that displayed differential
patterns of viral gene expression and were thus classified in
different kinetic classes were characterized. This study there-
fore provides a more complete analysis of the transcription
program of HCMV.
(Part of these results were presented at the 7th International
Cytomegalovirus Workshop in Brighton, United Kingdom,
28 April to 1 May 1999.)
MATERIALS AND METHODS
Selection and synthesis of oligonucleotides for DNA microarrays. The com-
plete set of ORFs from the HCMV genome was analyzed with a custom se-
* Corresponding author. Mailing address: Departments of Immu-
nology and Molecular Biology, Division of Virology, The Scripps Re-
search Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone:
(619) 784-8678. Fax: (619) 784-9272. E-mail: ghazal@scripps.edu.
† This is publication no. 12111-IMM from The Scripps Research
Institute.
5757
quence analysis program that selected a 75-base sequence to be used as a
microarray deposition target. The analysis preferentially selects unique se-
quences with a 39 gene bias and a G-C content of 40 to 60% and rejects
sequences that contain homopolymeric stretches and potential hairpin struc-
tures. The 39 gene bias is preferred, as fluorescently labelled cDNA prepared for
hybridization is generated by using oligo(dT) to prime poly(A) tails of mRNA.
The selected target sequences were synthesized by using a PE Perseptive Bio-
System (Framingham, Mass.) Expedite MOSS DNA synthesizer with membrane
columns. Synthesized gene target oligonucleotides were cleaved, deprotected,
and purified by standard procedures. Target oligonucleotides were transferred in
triplicate to 96-well master plates at a concentration of 1 mg/ml (in 33 SSC [13
SSC is 0.15 M NaCl plus 0.015 M sodium citrate]) for robotic deposition. The
sequence of oligonucleotides comprising the deposited HCMV ORF microarray
is shown in Fig. 1. The small ORF UL48/49 (8) and the UL74 ORF described by
Huber and Compton (13) were not included in the present chip design. Also
shown in Fig. 1 is a subset of cellular genes that were included as internal controls
for normalization between chips, as follows: elongation factor 1-alpha (accession
no. M29548), human acidic ribosomal phosphoprotein (RiboPO; accession no.
M17885), alpha tubulin (accession no. K00558), glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH; accession no. J04038), retinoic acid receptor (RARa1;
accession no. X06614), and CAAT box DNA binding protein (NFY; accession
no. X59711). Two plant homeobox genes, HAT 1 (accession no. UO9332) and
HAT 4 (accession no. Z19602) were deposited as further specificity controls.
Generation of microarrays, hybridization, and scanning. The preparation of
coated glass slides and the subsequent deposition printing of DNA was carried
out in a manner similar to that described previously (28). Briefly, a custom-made
microarrayer was built by using a Galil (Mountain View, Calif.) DMC1030-18
motion controller. The motion control signals were used to control NEMA 23
sized DC servo motors which drove Parker Dadeal (Harrison City, Pa.) 500,000
ET series linear stage with optical encoder feedback. The array table held up to
40 slides and one titer tray of source DNA targets for spotting. The custom-
designed spotting tip was based on the concept of a rod with a closed tweezer tip
manufactured to fit into a standard 384-well plate. The spotting tips were washed
in a custom-built wash-and-vacuum station before each round of spotting. The
entire spotting assembly was placed under a custom-made acrylic enclosure with
a class 100 HEPA filter (Envirco, Albuquerque, N. Mex.).
The HCMV chips used in this study were prepared by using a single-tip format.
The microarrayer tip delivered approximately 4 nl per spot on prescreened
silylated aldehyde-coated glass slides (CEL Associates, Houston, Tex.). Viral
microarrays were hybridized for 4 h under coverslips with a Cy3-dCTP (Amer-
sham)-labelled cDNA probe. The entire assembly was enclosed in a custom-
made hybridization chamber. After hybridization, the microarray slide assembly
was washed and dried. Microarrays were subsequently scanned by using a con-
focal laser ScanArray 3000 (General Scanning Inc.) system. Data were collected
at a maximum resolution of 10 mm/pixel with 16 bits of depth by using ImaGene
software (BioDiscovery Inc.).
Virus and cells. Human foreskin fibroblasts (HFF) were grown in Dulbecco’s
modified essential medium supplemented with 2 mM glutamine, 100 U of pen-
icillin per ml, 100 mg of gentamicin, and 10% fetal bovine serum. The Towne
strain of HCMV was used for all the experiments.
Viral infections, probe preparation, and labelling. HFF were mock infected or
infected with HCMV at a multiplicity of 5 PFU/cell. To assess IE transcription,
cultures were treated with cycloheximide (100 mg/ml) 1 h before infection, and
whole-cell RNA was harvested 13 h postinfection. For early transcription, gan-
ciclovir (100 mM) was added at the time of virus infection for 72 h prior to total
RNA isolation. Under these conditions, ganciclovir reduces virus yield by greater
than 99% (2). For late RNA isolation, whole-cell RNA was harvested from
cultures 72 h after infection. Mock-infected cells were treated with cycloheximide
or ganciclovir for the same period of time as infected HFF cultures were. Total
RNA was isolated from mock-infected and infected cells by using the RNAzol B
method (Tel-Test, Inc.; Friendswood, Tex.) according to the manufacturer’s
protocol. RNAs were passed through an RNAeasy Qiagen column after DNase
I treatment, and cDNA probes were synthesized. Fluorescently labelled cDNA
was prepared from RNA by oligo(dT)-primed polymerization by using super-
script II reverse transcriptase. The pool of nucleotides in the labelling reaction
consisted of 0.5 mM dGTP, dATP, and dTTP and 0.04 mM dCTP and fluores-
cent nucleotide Cy3-dCTP (Amersham) at 0.04 mM. Probes were purified by
using the Qiaquick PCR purification kit (Qiagen) and ethanol precipitation.
Statistical analysis. Quantitated hybridization levels were normalized so that
the 75th percentiles of the cellular gene expression levels were equal across chips.
HCMV gene expression was determined by comparing normalized values be-
tween mock-infected control chips and infected chips by using a Wilcoxon-Mann-
Whitney test (12).
Northern blot analysis. Total RNA, 14 mg per lane, was separated by electro-
phoresis on a 1% agarose gel containing 2.2 M formaldehyde, transferred onto
a nylon membrane (Hybond-N; Amersham), immobilized by UV cross-linking
(Stratagene, La Jolla, Calif.), and hybridized with 32P-labelled probes. The
probes for UL110 and US35 were composed of PCR-generated fragments. Prim-
ers used to amplify a 451-bp fragment from pCM1050 (7), a cosmid containing
the UL110 gene, were 18087 (59CATCAATCATCGTAGTGACGTC39) and
18088 (59GCCTATTGATAATAATCTACCCC39). Primers used to amplify a
211-bp fragment from pCM1035 (7), a cosmid containing the US35 gene, were
18119 (59GTACCGTTGTACGCATTACAC39) and 18120 (59GACGAAGATG
CCGATGTGTGAC39). The resulting PCR fragments were isolated from aga-
rose gels and then radiolabelled with [a-32P]dATP by the random-primed label-
ling method (Boehringer, Mannheim, Germany) according to the manufacturer’s
protocol. For TRL8-IRL8, TRL9-IRL9, UL15, UL31, UL48, UL66, and UL73,
the corresponding oligonucleotides shown in Fig. 1 were used as probes, after
being [a-32P]ATP end labelled with polynucleotide kinase (Stratagene). Oligo-
nucleotide probes were hybridized to the filters for 1 h at 45°C by using Quick
Hybridization solutions (Stratagene) under conditions recommended by the
manufacturer. PCR-generated probes were hybridized with the filters for 12 h at
65°C in 13 Denhardt’s solution, 63 SSC, and 100 mg of denatured salmon sperm
DNA/ml. Filters were washed to a stringency of 0.1% sodium dodecyl sulfate
(SDS) at 60°C or 1% SDS at 42°C depending whether PCR-generated DNA
fragments or oligonucleotides, respectively, were used during the hybridization.
Hybridization signals were quantitated by using a Molecular Dynamics Phospho-
rImager system with ImageQuant software.
MEME analysis of the upstream noncoding DNA sequences. The computer
program Multiple EM for Motif Elicitation (MEME) was used to search for
sequence motifs in 500 bp of noncoding sequences upstream of the initiation
codon. MEME analysis was performed by using the sequence of strain AD169 of
HCMV. The 59 noncoding regions were categorized according to class of ex-
pression as follows: E (TRL4-IRL4, UL104-5, UL11, UL112, UL124, UL13,
UL16-7, UL24, UL26-7, UL35, UL4-5, UL45, UL53-7, UL77-9, US8-14, US16-7,
US19, US23-4, US26, US28, and US30), early-late (E-L) (TRL-IRL6, TRL-
IRL10, TRL-IRL12, TRL-IRL13, UL1, UL106, UL130, UL40, UL44, UL46-7,
UL49, UL72, UL83-5, UL95-8, US6-7, and US29), and L (TRL-IRL8, TRL-
IRL11, TRL-IRL14, UL100, UL103, UL111A, UL117, UL119, UL131, UL14,
UL18, UL2-3, UL7, UL9, UL25, UL29, UL32-3, UL43, UL48, UL52, UL59,
UL67, UL73, UL80, UL82, UL91-3, UL99, US18, and US27). By using MEME,
30 motifs (10 of 8 bases in length, 10 of 10 bases in length or longer, and 10 of
12 bases in length or longer) were derived from each gene set. The distribution
of the combined 90 patterns was identified, allowing for 10% mismatch. MEME
is available on the World Wide Web (20a). The resulting motifs that developed
a significant polarized distribution pattern are summarized in Table 2. In addi-
tion, the transcription factor database (TFD) was used to search for known
regulatory sequences. The TFD was downloaded from the National Center for
Biotechnology Information.
RESULTS
Viral microarray (chip) of the HCMV genome. Microarray
technology provides an excellent method by which nucleic ac-
ids can be attached to a solid surface in a highly dense format.
Given that the HCMV genome consists of ;200 ORFs, the
entire set of potential genes can be easily arrayed in a small
area. With this capability and the availability of the complete
sequence of HCMV, our strategy was to use a directed ap-
proach for generating the viral genome array. This procedure
involved synthesizing a 75-base oligonucleotide corresponding
to the sense strand of each ORF. The length of this deposition
element provides a more efficient target for specific hybridiza-
tion than does a 25-base oligonucleotide and therefore affords
greater sensitivity. For these experiments, almost all ORFs
present in the AD169 laboratory strain of HCMV and four
ORFs from the Towne strain (UL147 and UL152-4) were
selected for deposition. In addition, a set of cellular genes (see
Materials and Methods for details; Fig. 1) and two plant genes
were included as controls. The generation of sense-strand oli-
gonucleotides as deposition elements has the advantage of the
assignation of polarity of transcription. In the present study,
the target oligonucleotide representing the ORF of interest
was arrayed in triplicate on glass slides. Three independent
experiments were performed for each experimental data point.
The viral arrays were less than 1 cm2 and contained approxi-
mately 1,000 elements, at a spacing of ;350 mm. This spacing
allows the hybridization volumes to be minimized (15 ml); thus,
2 mg of total RNA (from cells infected at a multiplicity of
infection [MOI] of 5) is sufficient for analysis, and subsequent
amplification steps are unnecessary.
Gene expression analysis by CMV microarrays. In this
study, the viral microarrays were used to delineate kinetic class
by examination of the drug sensitivity of viral gene expression.
The infection of permissive cells with HCMV in the presence
5758 CHAMBERS ET AL. J. VIROL.
FIG. 1. Oligonucleotides used in the microarray deposition.
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of an inhibitor of protein synthesis leads to the specific accu-
mulation of viral IE RNA. The IE genes of HCMV are well
characterized, and therefore a comparison with the results
from the viral microarray hybridization is a good first test of
the accuracy of the chip. Previously, it has been shown that
viral IE RNA arises from only a few distinct regions of the
genome and, on the basis of their levels of expression, can be
classified into two groups. The major IE genes, referred to as
IE1 (UL123) and IE2 (UL122), are transcribed and expressed
at relatively high levels. The other class of genes, including
primarily the US3, TRS1-IRS1, and UL36-38 loci, is expressed
at lower relative levels (reviewed in reference 22).
Accordingly, we used cycloheximide as an inhibitor of pro-
tein synthesis to investigate IE transcription of HCMV. For
these experiments, primary HFF cells were pretreated for 1 h
with 100 mg of cycloheximide/ml and subsequently mock in-
fected or infected with HCMV (Towne strain) at an MOI of 5.
RNA was isolated in five independent experiments, converted
to fluorescently labelled cDNA, and hybridized to the HCMV
chips. Fluorescence intensities were normalized by using a set
of cellular genes. An absolute fluorescent signal whose inten-
sity was greater than that observed over the mock-infected
control microarray element was considered to represent spe-
cific viral hybridization. Figure 2 (top panel) shows a scatter-
plot of these results, with the points above the line of equiva-
lence indicating expression. Conservatively, viral gene-specific
hybridization was considered significantly different between
mock-infected and infected samples only if the following two
criteria were met: (i) the median level of intensity in the in-
fected samples was at least threefold greater than that in the
mock-infected samples, and (ii) a nonparametric test for an
increase in level of intensity under conditions of virus infection
versus mock infection was significant at a P value of ,0.05. On
the basis of these criteria, four viral ORFs, as follows, were
specifically detected at IE: US3, UL122, UL123, and UL110.
The UL36-38, TRS1-IRS1 ORFs all showed ratios of approx-
imately 2, with P values of less than 0.05, and thus while they
showed a statistically significant increase, were not scored as
such under these selection conditions. It is noteworthy that
only two other ORFs (UL111A and US8) exhibited twofold
ratios. In the case of the UL110 ORF, the results of Northern
analysis corroborated the IE gene expression identified by the
microarray hybridization (Fig. 4). By the Northern analysis, a
5-kb transcript was detected that corresponds to a previously
characterized IE transcript reported from this region (15). As
a whole, these analyses show that while the CMV chip does not
score positive for all known IE genes, no false-positive signals
were detected. The false-negative results are likely due to poor
design of the target probe and/or related to level of sensitivity
for the detection of low-abundance transcripts. Nevertheless,
these experiments clearly demonstrate an efficacious approach
for the stringent detection of viral-specific RNA species and
thereby validate the microarray hybridization assay.
In the next set of experiments, we sought to determine the
profiles of the E and L kinetic classes of gene expression. The
influence of an inhibitor of viral DNA replication (e.g., ganci-
clovir) on HCMV gene expression differentiates E and L ki-
netic classes of viral transcripts. Strictly defined, an L gene is
one that is expressed after the onset of DNA replication al-
though, importantly, L genes can differ with respect to the
stringency of the requirement for DNA replication. Hence, in
the following experiments all L expression classes (E-L and L)
designate genes whose expression was reduced or eliminated
as shown by results for ganciclovir-treated versus untreated
genes. These ORFs are further classified as E-L or L, depend-
ing whether expression was detectable in the presence of a
replication inhibitor or not, respectively. For the purpose of
these experiments, HFF cells were infected with HCMV in the
presence of ganciclovir and harvested 72 h after infection for
early RNA or 72 h after infection with no drug treatment for
L-expression classes. Accordingly, RNAs from the various in-
fected and mock-infected controls were fluorescently labelled
and individually hybridized to the viral chip. The results of
these experiments are shown in Fig. 2, with the points above
the line of equivalence indicating E (middle panel) and L
(bottom panel) expression. By the chip, a viral gene was con-
sidered to be in the L-expression class if the following two
criteria were met: (i) the median level of intensity in the gan-
ciclovir-treated samples was at least threefold lower than that
FIG. 2. Microarray analysis of HCMV gene expression. (Top panel) Scatter-
plot of the normalized square root (sqrt) of the median level of expression of
mock-infected cells (triplicates, n 5 6) on abscissa in contrast to normalized
square root of the median level of expression of infected cells (triplicates, n 5 6)
under IE conditions. (Middle and lower panels) The same comparison shown in
the top panel is shown for E expression (n 5 3) (in the presence of ganciclovir)
and L expression (n 5 2) (in the absence of drug at 72 h postinfection). The
points above the line of equivalence exhibit the ORFs expressed. Representative
ORFs are indicated (see text for details). The point adjacent to IRL-4 represents
expression from a triplicate set of TRL-4 (n 5 3).
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in the untreated samples and (ii) a nonparametric test for a
decrease in the level of intensity in the ganciclovir-treated
samples versus that in the untreated samples was significant at
a P value less than 0.05. Array elements expressed at 72 h
postinfection in the presence or absence of ganciclovir were
analyzed by using the same criteria described for the IE gene
analysis, except that the median level of intensity was at least
twofold greater than that in the mock-infected samples. A
summary of the results for each ORF is shown in Table 1 and
Fig.2. Figure 3 shows a graphic representation of the sensitivity
of gene expression to ganciclovir treatment at L times. Note
the marked variation in the extent of the inhibition of L gene
expression (points distributed outside the shaded circle) to the
viral replication inhibitor (Fig. 3). Under these conditions, only
a few ORFs showed greater-than-10-fold sensitivity to ganci-
clovir (TRL-IRL8, TRL-IRL12, UL43, UL49, UL52, UL85,
UL86, UL94, UL106, UL111A, UL130, UL152 [Towne], and
US6). The aberrantly high ratio for UL130 is due to very low
levels of E expression that are likely the result of a suboptimal
deposition target. In Table 1, ORFs expressed at 72 h postin-
fection in the absence of ganciclovir include L designations
(E-L and L), while ORFs unaffected by drug treatment are
marked as an E class. These data reveal that greater than 75%
of the genome is transcriptionally active at 72 h postinfection.
Of the genes mapped, 36% were classified as E, 26% were
classified as E-L, and 32% were classified as L. Thus, the
majority of genes belong to L expression classes. No correla-
tion between members of a gene family (RL11, US6, US12,
and US22 families) and temporal class of gene expression was
observed, indicating divergence of regulatory control pathways
of these family members. In marked contrast to the genes in
the UL region, the US genes are predominantly (70%) allo-
catable to the E kinetic class of expression. It should be noted
that approximately 20% of the arrayed ORFs scored negative
for expression. In several cases (UL11, UL16, UL25, UL70,
UL99, UL117-9, and US2), the ORFs are known to be active
genes (Table 1), suggesting that other previously uncharacter-
ized ORFs which did not develop a positive signal in the
microarray analysis may well be transcriptionally active. To
determine whether this is the case, we performed Northern
blot analysis for selected ORFs (US35, UL66, and UL127) that
were not scored in the chip analysis or previously studied. In
the presence of ganciclovir at 72 h postinfection, RNA levels
for UL66 are detectable but not as high as those without drug
treatment, indicating that UL66 ORF is transcribed with E-L
expression kinetics (Fig. 4). In addition, the US35 ORF is
weakly transcribed (Fig. 4). Levels of the US35 RNA are un-
altered by ganciclovir treatment, implying that this transcript
can be classified as E. We were unable to detect a specific
transcript for UL127 by probing Northern blots, consistent
with the chip analysis (data not shown). We also note that a
number of these ORFs are very small and may not constitute
bona fide genes (e.g., UL12, UL90, US4, US5, and US36).
Overall, these results indicate that the present chip analysis
detects approximately 75% of known or predicted ORFs in the
HCMV genome.
The expression profiles of many of the ORFs identified by
chip analysis were not previously known, although the tran-
scription of a limited number of E and E-L genes and that of
even fewer L genes have been described previously (Table 1).
Notably, the expression patterns we observed by chip analysis
for previously characterized genes showed almost perfect con-
cordance with previously published results. However, there are
a few exceptions, namely, UL102, TRL6, UL33, UL83, UL86,
US18, and US27. By the present chip analysis, UL102 is clas-
sified as an E-L ORF, while previous work (29) indicates that
UL102 is an E gene that is not expressed at L times. However,
in a study by Smith and Pari (29), an overlapping transcript is
present exclusively at L times and is selectively inhibited by
DNA replication inhibitors. Therefore, the chip array cannot
distinguish overlapping transcripts, and consequently UL102
would be allocated to both expression classes. Similarly, US18
is a true L gene, but its transcript is expressed at relatively low
levels compared with those of the overlapping E transcripts of
US19 and US20 (9). Thus, it is not surprising that the chip
would designate US18 as an E gene. In the case of the US27
and UL33 L genes, the chip analysis indicated a ratio of ap-
proximately 2.6- and 2.4-fold decreases, respectively, with P
values of less than 0.05; thus, while these genes show a statis-
tically significant sensitivity to ganciclovir, they are not assessed
as such under the selection conditions. These exceptions un-
derscore some limitations of the present chip approach, al-
though the chip results show approximately 90% agreement
overall with published studies. Nevertheless, to further corrob-
orate the microarray results, RNA levels of selected ORFs
(TRL8-IRL8, TRL9-IRL9, UL15, UL31, UL48, UL68, and
UL73) that have not been previously studied were measured by
Northern blot analysis. Based on the microarray hybridization,
we expected all these selected ORFs to exhibit L expression
characteristics. Figure 4 (lanes 2) indicates that none of the
messages are transcribed at IE times in the presence of cyclo-
heximide. In the presence of ganciclovir at 72 h postinfection,
transcripts for TRL8-IRL8, TRL9-IRL9, UL15, UL31, UL48,
UL66, UL68, and UL73 were not well developed (except for
the TRL8-IRL8 transcript) compared with those at 72 h
postinfection without drug treatment, indicating that these
messages have an L classification (Fig. 4, lanes 3 and 4). Al-
together, these results are in concordance with the microarray
results and further confirm the reliability and accuracy of the
viral chip approach.
Examining upstream noncoding DNA sequence of HCMV E,
E-L, and L genes. The above experiments designate the kinetic
class of expression of more than 150 ORFs, most of which have
not been previously characterized. To date, little is known
about how the kinetics of HCMV gene expression are con-
trolled, in part because thus far, relatively few genes have been
studied. Relatedly, the regulation of DNA-virus gene expres-
sion involves the interaction of host-encoded and viral proteins
with discrete elements (DNA or RNA) in the 59-end region of
the gene. Therefore, to gain further insight into the regulation
of the kinetics of HCMV gene expression, we examined a set
of upstream DNA sequences corresponding to 40 E, 27 E-L,
and 36 L ORFs that contain an initiation codon. The rationale
for examining this set of upstream regions was that perhaps, as
in some viral systems (24), a single regulatory motif may act
either as a negative or a positive regulator of gene expression,
depending on its kinetic class. The upstream DNA sequence
corresponding to each ORF was bounded at the 39 end by the
ORF’s translation start. The 59 end of the upstream region was
designated as being 500 bp from the translation start. This
choice of the upstream-region boundaries was justified, as
most genes have control elements that lie between 0 and 500
bp upstream of the translation start. In the present study, we
used the MEME algorithm (one of several algorithms devel-
oped for discovering recurring motifs in unaligned sequences)
to search for common motifs within a given kinetic class (see
Materials and Methods for details). The results of this analysis,
summarized in Table 2, indicate no readily apparent single,
dominant element unique to a kinetic class. However, a subset
of E, E-L, and L promoter regions have in common conserved
sequence motifs of about 8 to 12 bp in length. For example, 25
and 11% of E and E-L promoter regions, respectively, contain
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TABLE 1. Kinetic class of HCMV ORF expression
ORF (strain)
Class by indicated
assay or source ORF (strain)
Class by indicated
assay or source
Chip Northern (reference) Chip Northern (reference)
JIL E UL86 E-L L (22)
TRL2-IRL2 E UL89 E-L
TRL3-IRL3 L UL91 L
TRL4-IRL4 E E (22) UL92 L
TRL5-IRL5 E (14) UL93 L
TRL6-IRL6 L E-L (14) UL94 L L (38)
TRL7-IRL7 E UL95 E-L (37)
TRL8-IRL8 L L (N) UL96 E-L E-L (21, 32)
TRL9-IRL9 L L (N) UL97 E-L E-L (21, 32)
TRL10-IRL10 E-L UL98 E-L E-L (5, 37)
TRL11-IRL11 L UL99 L (22)
TRL12-IRL12 E-L UL100 E-L L (22)
TRL13-IRL13 E-L UL102 L E, I (29)
TRL14 L UL103 L
IRL14 E UL104 E
UL1 E-L UL105 E E (30)
UL2 L UL106 E-L
UL3 L UL107 L
UL4 E E (22) UL108 L
UL5 E UL109 L
UL7 L UL110 IE, E, L IE, L(N) (15)
UL9 L UL111 L
UL11 E (11) UL111A E-L L (26)
UL13 E UL112 E E (22)
UL14 L UL113 E-L E (22)
UL15 L L (N) UL114 E
UL16 E (17) UL115 L (22)
UL17 E UL116 E-L L (22)
UL18 L L (22) UL117 L (22)
UL21 L UL118 E L (22)
UL25 L (1) UL119 E L (22)
UL26 E UL120 L
UL27 E UL121 L
UL29 L UL122 IE, L IE, L (22)
UL31 L L (N) UL123 IE IE (22)
UL32 L L (22) UL124 E
UL33 E L (22) UL128 E
UL34 E-L L (22) UL129 L
UL35 E UL130 E-L
UL36 E IE (22) UL131 L
UL37 IE (22) UL132 E-L
UL38 IE (22) UL147 (Towne) E-L
UL40 E-L UL152 (Towne) E-L
UL41 L UL153 (Towne) E-L
UL43 L UL154 (Towne) E-L
UL44 E-L E-L (22) IRS1-TRS1 IE (22)
UL46 E-L US2 E (22)
UL47 E-L US3 IE IE (22)
UL48 L L (N) US6 E-L E-L (16)
UL49 E-L US7 E-L E-L (16)
UL52 L US8 E E (16)
UL53 E US9 E E (16)
UL54 E E (22) US10 E E (16)
UL55 E E (22) US11 E E (16)
UL56 E E (22) US12 E
UL57 E E (22) US13 E
UL58 E E US14 E
UL59 L US15 E-L
UL60 L US16 E
UL63 E US17 E
UL66 E-L (N) US18 E L (9)
UL67 L US19 E E (9)
UL68 L L (N) US20 E E (9)
UL69 E-L E-L (39) US22 E E (22)
Continued on facing page
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the sequence pattern ACGACGTCGG, which harbors a core
ATF recognition site (underlined sequence) (Table 2). By con-
trast, the palindromic sequence pattern CCGCGGGCGCGG
is present in 17% of L promoters alone and does not match any
known transcription factor binding site (Table 2). The up-
stream noncoding regions were further analyzed for the pres-
ence of binding sites common to known transcription factors by
using the TFD. In general, L promoters contained fewer bind-
ing sites to known transcription factors than did promoters in
the E and E-L expression classes (data not shown). This ob-
servation may correlate with a reduction in the complexity of
the transcriptional control regions associated with the L ex-
pression class. Overall, we conclude that HCMV kinetic classes
of promoters may be characterized not by discrete consensus
sequence motifs but, instead, by common subsets of related
sites, indicating more-elaborate regulatory pathways.
DISCUSSION
This study evaluates a novel approach for profiling the gene
expression of large DNA viruses. By applying DNA chip tech-
nology, which has been successfully used with a number of
microorganisms (references 27 and 28 and references therein)
to monitor genome-wide transcription, we were able to specif-
ically detect HCMV-expressed messages in the context of
abundant cellular RNAs by using oligonucleotides correspond-
ing to each ORF of the HCMV genome. The obvious advan-
tage this system has over traditional methods is the speed with
which global changes in CMV transcription can be simulta-
neously monitored. These fabricated DNA microarrays greatly
extend and complement existing RNA transcript-mapping pro-
cedures, such as Northern analysis, slot blot, reverse transcrip-
tion-PCR, primer extension, and nuclease protection-based
methods.
In this study we were able to detect, in parallel, the expres-
sion of a total of 151 HCMV ORFs. A comparison of the
results we obtained by viral microarray hybridization with pre-
viously reported results provided a good test for the sensitivity
and accuracy of the chip approach. The expression patterns we
observed by chip analysis for previously characterized genes
showed almost-perfect concordance with results published ear-
lier. In addition, we further characterized by Northern analysis
TRS8-IRS8, TRS9-IRS9, UL15, UL31, UL48, UL68, and
UL73 expression patterns. In each case tested, there was com-
plete agreement with the chip analysis. Overall, the HCMV
chip proved to be a reliable and robust assay, as the false-
negative rate was low (;10%), providing confidence in the
reliability of the analysis determined in this study. The rate of
false-negative results can be decreased in the future by select-
ing different oligonucleotides or by using PCR fragments for
deposition. It is important that the microarray approach for
defining the kinetic class of gene expression has limitations in
distinguishing overlapping viral messages that may be under
the control of multiple promoter elements, allowing the assig-
nation of expression to more than one kinetic class (e.g.,
UL102 and US18). In this case, the false-positive rate (,15%)
was primarily due to overlapping transcription units. The
present analysis probably underestimates the full expression
profile of HCMV, since we measured only predicted ORFs,
FIG. 3. Sensitivity of HCMV gene expression to ganciclovir treatment. The
fold decrease in levels of gene expression in cells 72 h postinfection treated with
ganciclovir or left untreated are represented by concentric circles. Each ORF was
arbitrarily assigned a radial spacing of approximately 1°. The inner, shaded circle
shows values that exhibit threefold-or-less change in normalized median levels of
expression (n 5 3). The outer boxed point is off scale, and the name of the ORF
(UL130) and fold decrease (919-fold) are marked. Representative ORFs are
indicated.
TABLE 1—Continued
ORF (strain)
Class by indicated
assay or source ORF (strain)
Class by indicated
assay or source
Chip Northern (reference) Chip Northern (reference)
UL70 E-L (39) US23 E
UL72 E-L US24 E
UL73 E-L L (N) US25 E-L
UL75 E-L L (22) US26 E
UL77 E US27 E L (33)
UL78 E US28 E E (33)
UL80 L (35) US29 E-L
UL81 L US30 E
UL82 L L (22) US32 L
UL83 L E-L (22) US33 E
UL84 E-L E-L (10, 22) US34 E
UL85 E-L US35 E (N)
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and some of the viral ORF array DNAs may not be optimal
(e.g., UL66, US2, and UL99). More-detailed RNA-mapping
experiments will be required to fully characterize the program
of HCMV transcription.
Identification and characterization of regulatory sequences
are critical to elucidating global mechanisms of transcriptional
regulation. The distribution of ORFs to a specific expression
class was used to search for regulatory motifs possibly associ-
ated with a set of coregulated genes. Automatic alignments
obtained by using MEME algorithms of the upstream noncod-
FIG. 4. Northern blot analysis of selected HCMV ORF transcripts. Whole-cell RNA was harvested either from uninfected cells (lane 1) or HCMV-infected cells
at 13 h postinfection in the presence of cycloheximide (lane 2) or 72 h postinfection in the absence (lane 4) or presence (lane 3) of ganciclovir. RNAs were separated
on formaldehyde-agarose gels, transferred to a nylon membrane, and hybridized with radiolabelled probes specific for selected viral transcripts (details in Materials and
Methods). The probes used are indicated at the top of the lanes. The position and approximate size of the major viral transcript(s) detected in each case are indicated
on the right of each panel. The 1.4-kb GAPDH band detectable in all lanes is indicated by an arrow to the left of the lower panels.
TABLE 2. MEME analysis of E, E-L, and L 59 noncoding regions
ORF class
(total no.)
ORFs with indicated MEME pattern (respective % of E, E-L, and L ORFs)
ACGACGTCGG
(25, 11, 0)
AAAACAACGT
(25, 19, 3)
TGACGGTG
(13, 30, 6)
CGGTCTTCTTTT
(0, 0, 14)
CCGCGGGCGCGG
(0, 0, 17)
E (n 5 40) UL104 UL11 US11
UL16 UL112 US13
UL26 UL35 US17
UL27 UL5 US24
UL35 UL57 US30
UL56 UL77
UL57 US11
US19 US17
US28 US24
US9 US30
E-L (n 5 27) UL46 IRL10 IRL12
UL49 IRL13 IRL13
UL96 TRL10 TRL12
TRL13 TRL13
UL44 UL49
UL83
UL97
UL98
L (n 5 36) UL52 UL92 IRL8 IRL8
US18 TRL8 TRL8
UL25 UL25
UL32 UL32
UL33 UL33
UL48
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ing DNA sequences of many of the coregulated ORFs did not
readily identify a unique class-specific consensus sequence mo-
tif. However, a subset of E, E-L, and L genes was found to
contain a conserved sequence motif, indicating redundancy in
the use of specific elements or perhaps a more complex regu-
latory hierarchy. Further investigation will be required to as-
sess the role of the regulatory sequences suggested by these
experiments.
The position and pairwise polarity of genes may strongly
influence their transcription, especially in viral genomes, since
limited intergenic sequence necessitates the sharing of up-
stream regulatory elements. Little evidence was observed for a
direct correlation between kinetic class and location or polarity
of transcription in infection, as illustrated by the UL112-113
and UL122-123 E and IE regions, respectively. The divergent
UL111A ORF is close to the UL112-113 E promoter, yet it
displays L expression characteristics. The divergent ORF
UL127 is immediately proximal to the major IE enhancer for
UL122-123 but is not apparently expressed. Consistent with
the chip data, we failed to detect UL127 transcripts by North-
ern analysis. However, 70% of the US genes exhibit the E
kinetic class of expression. Thus, the HCMV genome may be
able to accommodate more elaborate control of its transcrip-
tion program than smaller viral genomes. Evolutionarily, large
viral genomes such as HCMV may thus have been provided
with a selective advantage.
Viral microarrays have many other potential uses. For in-
stance, viral DNA microarrays may be used to characterize
transcripts associated with latency and viral programs of tran-
scription in different tissues and cell types. Viral chips will be
particularly useful in analyzing the transcriptional conse-
quences of mutations affecting the activity of host and viral
regulatory molecules. This combination of genetics with DNA
chip analysis will provide a powerful approach to the dissection
and characterization of the infectious program and associated
regulatory networks in a variety of biologically important cell
types. This strategy also has important practical applications in
antiviral drug screening. DNA microarrays can be used to
define the signature pattern of known viral inhibitors (e.g., this
study) and can also be used to screen for compounds that
develop an alternatively desired signature (18). Moreover, mu-
tations in specific genes encoding potential drug targets can
serve as surrogates for chemical inhibitors of their activity.
Viral chips can also be used to monitor drug resistance by
expression profiling and typing genotypic strain variation (40)
in clinical samples and thus serve as a valuable diagnostic tool.
In summary, we have developed a viral microarray-based
approach to transcriptionally map the genome of HCMV. In
the present study, we used viral microarray chips to profile the
drug sensitivity of viral gene expression and delineate the ki-
netic classes of the majority of the predicted ORFs in the
HCMV genome. In the future, viral and cellular DNA mi-
croarrays (41) will be a rich source of useful insights into viral
biology and contribute to a deeper understanding of the gene
pathways involved in viral growth and pathogenesis.
ACKNOWLEDGMENTS
J.C. and A.A. contributed equally to this work.
This work was supported by grants from the National Institutes of
Health to P.G. (CA-66167 and AI-30627). P.G. is a Scholar of the
Leukemia Society of America. A.A. is a Fellow of the Universitywide
AIDS Research Program.
We thank Kathy Witmeyer, Jon Fleismann, and Dave Ladmer for
cooperation in designing, synthesizing and purifying the gene targets;
Mehrdad Khaleghi and John Wittig for help with data collection;
Kenny Simmen for help with Northern blot analysis; Fatima Garcia del
Rey for cooperation in preparing viral master plates for robotic print-
ing; and Tom Hasse for the CAD layouts and machine work. Last, we
apologize to the investigators whose work on the characterization of
transcription units in the HCMV genome we unintentionally neglected
to cite. We thank Kelly White for assistance in the preparation of the
manuscript.
REFERENCES
1. Baldick, C. J., Jr., and T. Shenk. 1996. Proteins associated with purified
human cytomegalovirus particles. J. Virol. 70:6097–6105.
2. Barnard, D. L., J. H. Huffman, R. W. Sidwell, and E. J. Reist. 1993. Selective
inhibition of cytomegaloviruses by 9-(39-ethylphosphono-19-hydorxymethyl-
19-propyloxy-methyl) guanine. Antiviral Res. 22:77–89.
3. Cha, T.-A., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R.
Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes
not found in laboratory strains. J. Virol. 70:78–83.
4. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T.
Horsnell, C. A. Hutchison III, T. Kouzarides, J. A. Martignetti, E. Preddie,
S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990.
Analysis of the protein-coding content of the sequence of human cytomeg-
alovirus strain AD169. Curr. Top Microbiol. Immunol. 154:125–170.
5. DeMarchi, J. M., C. A. Schmidt, and A. S. Kaplan. 1980. Patterns of tran-
scription of human cytomegalovirus in permissively infected cells. J. Virol.
35:277–286.
6. DeRisi, J., L. Penland, P. O. Borwn, M. L. Bittner, P. S. Meltzer, M. Ray, Y.
Chen, Y. A. Su, and J. M. Trent. 1996. Use of a cDNA microarray to analyse
gene expression. Nat. Genet. 14:457–460.
7. Fleckenstein, B., I. Mullerand, and J. Collins. 1982. Cloning of the complete
human cytomegalovirus genome in cosmids. Gene 18:39–46.
8. Gibson, W., K. S. Clopper, W. J. Britt, and M. K. Baxter. 1996. Human
cytomegalovirus (HCMV) smallest capsid protein identified as product of
short open reading frame located between HCMV UL48 and UL49. J. Virol.
70:5680–5683.
9. Guo, Y.-W., and E.-S. Huang. 1993. Characterization of a structurally tricis-
tronic gene of human cytomegalovirus composed of US18, US19, and US20.
J. Virol. 67:2043–2054.
10. He, Y. S., L. Xu, and E.-S. Huang. 1992. Characterization of human cyto-
megalovirus UL84 early gene and identification of its putative protein prod-
uct. J. Virol. 66:1098–1108.
11. Hitomi, S., H. Kozuka-Hata, Z. Chen, S. Sugano, N. Yamaguchi, and S.
Watanabe. 1997. Human cytomegalovirus open reading frame UL11 encodes
a highly polymorphic protein expressed on the infected cell surface. Arch.
Virol. 142:1407–1427.
12. Hollander, M., and D. A. Wolfe. 1973. Nonparametric statistical analysis.
John Wiley, New York, N.Y.
13. Huber, M. T., and T. Compton. 1998. The human cytomegalovirus UL74
gene encodes the third component of the glycoprotein H-glycoprotein L-
containing envelope complex. J. Virol. 72:8191–8197.
14. Hutchinson, N. I., R. T. Sondermeyer, and M. J. Tocci. 1986. Organization
and expression of the major genes from the long inverted repeat of the
human cytomegalovirus genome. Virology 155:160–171.
15. Jahn, G., E. Knust, H. Schmolla, T. Sarre, J. A. Nelson, J. K. McDougall,
and B. Fleckenstein. 1984. Predominant immediate-early transcripts of hu-
man cytomegalovirus AD169. J. Virol. 49:363–370.
16. Jones, T. R., and V. P. Muzithras. 1991. Fine mapping of transcripts ex-
pressed from the US6 gene family of human cytomegalovirus strain AD169.
J. Virol. 65:2024–2036.
17. Kaye, J., H. Browne, M. Stoffel, and T. Minson. 1992. The UL16 gene of
human cytomegalovirus encodes a glycoprotein that is dispensable for
growth in vitro. J. Virol. 66:6609–6615.
18. Marton, M. J., J. L. DeRisi, H. A. Bennett, V. R. Iyer, M. R. Meyer, C. J.
Roberts, R. Stoughton, J. Burchard, D. Slade, H. Dai, D. E. Bassett, Jr.,
L. H. Hartwell, P. O. Brown, and S. H. Friend. 1998. Drug target validation
and identification of secondary drug target effects using DNA microarrays.
Nat. Med. 4:1293–1301.
19. McDonough, S. H., and D. H. Spector. 1983. Transcription in human fibro-
blasts permissively infected by human cytomegalovirus strain AD169. Virol-
ogy 125:31–46.
20. McDonough, S. H., S. I. Staprans, and D. H. Spector. 1985. Analysis of the
major transcripts encoded by the long repeat of human cytomegalovirus
strain AD169. J. Virol. 53:711–718.
20a.MEME algorithm. 1994, copyright date. [Online.] Regents of the University
of California. www.sdsc.edu/meme/website/intro.html. [25 Feb. 1998, last
date accessed.]
21. Michel, D., I. Pavic, A. Zimmermann, E. Haupt, D. Wunderlich, M. Heus-
chmid, and T. Merthens. 1996. The UL97 gene product of human cytomeg-
alovirus is an early-late protein with a nuclear localization but is not a
nucleoside kinase. J. Virol. 70:6340–6346.
22. Mocarski, E. S. 1996. Cytomegalovirus and their replication, p. 2447. In B. N.
Fields, K. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed. Lippincott-
Raven Publishers, Philadelphia, Pa.
VOL. 73, 1999 VIRAL DNA CHIP: PARALLEL EXPRESSION ANALYSIS OF HCMV 5765
23. Mocarski, E. S., M. N. Prichard, C. S. Tan, and J. M. Brown. 1997. Reas-
sessing the organization of the UL42-UL43 region of the human cytomeg-
alovirus strain AD169 genome. Virology 239:169–175.
24. Moss, B. 1990. Regulation of vaccinia virus transcription. Annu. Rev. Bio-
chem. 59:661–688.
25. Ramsay, G. 1997. DNA chips: state-of-the-art. Nat. Biotechnol. 16:40–44.
26. Razzaque, A., N. Jahn, and D. McWeeney. 1988. Localization and DNA
sequence analysis of the transforming domain (mtrII) of human cytomega-
lovirus. Proc. Natl. Acad. Sci. USA 85:5705–5793.
27. Schena, M. 1996. Genome analysis with gene expression microarrays. Bioes-
says 18:427–431.
28. Schena, M., D. Shalon, R. W. Davis, and P. O. Brown. 1995. Quantitative
monitoring of gene expression patterns with a complementary DNA mi-
croarray. Science 270:467–470.
29. Smith, J. A., and G. S. Pari. 1995. Human cytomegalovirus UL102 gene.
J. Virol. 69:1734–1740.
30. Smith, J. A., S. Jairath, J. J. Crute, and G. S. Pari. 1996. Characterization of
the human cytomegalovirus UL105 gene and identification of the putative
helicase protein. Virology 220:251–255.
31. Stinski, M. F., D. R. Thomsen, R. M. Stenberg, and L. C. Goldstein. 1983.
Organization and expression of the immediate early genes of human cyto-
megalovirus. J. Virol. 46:1–14.
32. van Zeijl, M., J. Fairhurst, E. Z. Baum, L. Sun, and T. R. Jones. 1997. The
human cytomegalovirus UL97 protein is phosphorylated and is a component
of virions. Virology 231:72–80.
33. Vieira, J., T. J. Schall, L. Corey, and A. P. Geballe. 1998. Functional analysis
of the human cytomegalovirus US28 gene by insertion mutagenesis with the
green fluorescent protein gene. J. Virol. 72:8158–8165.
34. Wathen, M. W., and M. F. Stinski. 1982. Temporal patterns of human
cytomegalovirus transcription: mapping the viral RNAs synthesized at im-
mediate early, early, and late times after infection. J. Virol. 41:462–477.
35. Welch, A. R., L. M. McNally, and W. Gibson. 1991. Cytomegalovirus assem-
bly protein nested gene family: four 39-coterminal transcripts encode four
in-frame, overlapping proteins. J. Virol. 65:4091–4100.
36. Wilkinson, G. W. G., A. Akrigg, and P. J. Greenaway. 1984. Transcription of
the immediate early genes of human cytomegalovirus strain AD169. Virus
Res. 1:101–116.
37. Wing, B. A., and E.-S. Huang. 1995. Analysis and mapping of a family of
39-coterminal transcripts containing coding sequences for human cytomeg-
alovirus open reading frames UL93 through UL99. J. Virol. 69:1521–1531.
38. Wing, B. A., G. C. Y. Lee, and E.-S. Huang. 1996. The human cytomegalo-
virus UL94 open reading frame encodes a conserved herpesvirus capsid/
tegument-associated virion protein that is expressed with true late kinetics.
J. Virol. 70:3339–3345.
39. Winkler, M., S. A. Rice, and T. Stamminger. 1994. UL69 of human cyto-
megalovirus, an open reading frame with homology to ICP27 of herpes
simplex virus, encodes a transactivator of gene expression. J. Virol. 68:3943–
3954.
40. Winzler, E. A., D. R. Richards, A. R. Conway, A. L. Goldstein, S. Kalman,
M. J. McCullough, J. H. McCusker, D. A. Stevens, L. Wodicka, D. J. Lock-
hart, and R. W. Davis. 1998. Direct allelic variation scanning of the yeast
genome. Science 281:1194–1197.
41. Zhu, H., J. P. Cong, G. Mamtora, T. Gingeras, and T. Shenk. 1998. Cellular
gene expression altered by human cytomegalovirus: global monitoring with
oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 24:14470–14475
5766 CHAMBERS ET AL. J. VIROL.
